Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope and definitions
1.3 Base estimates and working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Pharmaceutical drug delivery industry 3600 synopsis, 2018 - 2032
2.2 Business trends
2.3 Route of administration trends
2.4 Application trends
2.5 Facility of use trends
2.6 Regional trends
Chapter 3 Pharmaceutical Drug Delivery Market Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rising prevalence of chronic diseases
3.3.1.2 Growth in the biologics market
3.3.1.3 Technological advancement and new product launches
3.3.1.4 Increasing investment in pharmaceutical R&D
3.3.1.5 Self-administration and home care
3.3.2 Industry pitfalls & challenges
3.3.2.1 Risk of needlestick injuries
.3.3.2.2. Cost intensive drug development process
3.4 Growth potential analysis
3.4.1 By route of administration
3.4.2 By application
3.4.3 By facility of use
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.7 Porter's analysis
3.8 PESTLE Analysis
Chapter 4 Competitive landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive positioning matrix, 2022
4.4 Company market share analysis, 2022
4.5 Strategic outlook matrix, 2022
4.6 Strategy dashboard, 2022
Chapter 5 Pharmaceutical Drug Delivery Market, By Route of Administration
5.1 Key segment trends
5.2 Oral drug delivery
5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.2.2 Solid oral drugs
5.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.2.2.2 Tablets
5.2.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.2.2.3 Capsules
5.2.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.2.2.4 Powder
5.2.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.2.2.5 Pills
5.2.2.5.1 Market size, by region, 2018 - 2032 (USD Million)
5.2.3 Liquid oral drugs
5.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.2.3.2 Syrups
5.2.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.2.3.3 Solutions
5.2.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.2.4 Semi-solid oral drugs
5.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.2.4.2 Gels
5.2.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.2.4.3 Emulsions
5.2.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.2.4.4 Elixirs
5.2.4.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Injectable drug delivery
5.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.2 Conventional injection devices
5.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.2.2 By material
5.3.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.2.2.2 Glass syringes
5.3.2.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.2.2.3 Plastic syringes
5.3.2.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.2.3 By product
5.3.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.2.3.2 Fillable syringes
5.3.2.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.2.3.3 Prefilled syringes
5.3.2.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.2.4 By usability
5.3.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.2.4.2 Reusable syringes
5.3.2.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.2.4.3 Disposable syringes
5.3.2.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.3 Self-injection devices
5.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.3.2 Needle-free injectors
5.3.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.3.3 Autoinjectors
5.3.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.3.4 Pen injectors
5.3.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.3.5 Wearable injectors
5.3.3.5.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.4 Other injector devices
5.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.4 Topical drug delivery
5.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.4.2 Liquid formulations
5.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.4.2.2 Solutions
5.4.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.4.2.3 Suspensions
5.4.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.4.3 Semi-solid formulations
5.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.4.3.2 Creams
5.4.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.4.3.3 Gels
5.4.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.4.3.4 Ointments
5.4.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.4.3.5 Pastes
5.4.3.5.1 Market size, by region, 2018 - 2032 (USD Million)
5.4.3.6 Lotions
5.4.3.6.1 Market size, by region, 2018 - 2032 (USD Million)
5.4.4 Solid formulations
5.4.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.4.4.2 Suppositories
5.4.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.4.4.3 Powders
5.4.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.4.5 Transdermal products
5.4.5.1 Market size, by region, 2018 - 2032 (USD Million)
5.4.5.2 Transdermal patches
5.4.5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.4.5.3 Transdermal gels
5.4.5.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.5 Ocular drug delivery
5.5.1 Market size, by region, 2018 - 2032 (USD Million)
5.5.2 Liquid formulations
5.5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.5.2.2 Eye drops
5.5.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.5.2.3 Liquid sprays
5.5.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.5.3 Semi-solid formulations
5.5.3.1.1 Market size, by region, 2018 - 2032 (USD Million)
5.5.3.2 Gels
5.5.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.5.3.3 Eye ointments
5.5.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.5.4 Ocular devices
5.5.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.5.4.2 Drug-coated contact lenses
5.5.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.5.4.3 Ocular inserts
5.5.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.6 Pulmonary drug delivery
5.6.1 Market size, by region, 2018 - 2032 (USD Million)
5.6.2 Metered-dose inhalers
5.6.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.6.3 Dry powder inhalers
5.6.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.6.4 Nebulizers
5.6.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.6.4.2 Jet nebulizers
5.6.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.6.4.3 Ultrasonic nebulizers
5.6.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.6.4.4 Soft mist nebulizers
5.6.4.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.7 Nasal drug delivery
5.7.1 Market size, by region, 2018 - 2032 (USD Million)
5.7.2 Nasal drops
5.7.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.7.3 Nasal sprays
5.7.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.7.4 Nasal powders
5.7.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.7.5 Nasal gels
5.7.5.1 Market size, by region, 2018 - 2032 (USD Million)
5.8 Transmucosal drug delivery
5.8.1 Market size, by region, 2018 - 2032 (USD Million)
5.8.2 Oral formulations
5.8.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.8.2.2 Buccal drug delivery
5.8.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.8.2.3 Sublingual drug delivery
5.8.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.8.3 Other transmucosal drug delivery technologies
5.8.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.8.3.2 Rectal drug delivery
5.8.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.8.3.3 Vaginal drug delivery
5.8.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.9 Implantable drug delivery
5.9.1 Market size, by region, 2018 - 2032 (USD Million)
5.9.2 Active implantable drug delivery
5.9.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.9.3 Passive implantable drug delivery
5.9.3.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 6 Pharmaceutical Drug Delivery Market, By Application
6.1 Key segment trends
6.2 Infectious diseases
6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 Cancer
6.3.1 Market size, by region, 2018 - 2032 (USD Million)
6.4 Cardiovascular diseases
6.4.1 Market size, by region, 2018 - 2032 (USD Million)
6.5 Diabetes
6.5.1 Market size, by region, 2018 - 2032 (USD Million)
6.6 Respiratory diseases
6.6.1 Market size, by region, 2018 - 2032 (USD Million)
6.7 Central nervous system disorders
6.7.1 Market size, by region, 2018 - 2032 (USD Million)
6.8 Autoimmune diseases
6.8.1 Market size, by region, 2018 - 2032 (USD Million)
6.9 Other applications
6.9.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 7 Pharmaceutical Drug Delivery Market, By Facility of Use
7.1 Key segment trends
7.2 Hospitals
7.2.1 Market size, by region, 2018 - 2032 (USD Million)
7.3 Ambulatory surgical centers and clinics
7.3.1 Market size, by region, 2018 - 2032 (USD Million)
7.4 Home care settings
7.4.1 Market size, by region, 2018 - 2032 (USD Million)
7.5 Diagnostic centers
7.5.1 Market size, by region, 2018 - 2032 (USD Million)
7.6 Other facilities of use
7.6.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 8 Pharmaceutical Drug Delivery Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Switzerland
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Pfizer Inc.
9.2 Johnson & Johnson
9.3 AbbVie Inc.
9.4 Merck & Co., Inc.
9.5 Sanofi
9.6 Bayer AG
9.7 Amgen, Inc
9.8 AstraZeneca plc
9.9 Eli Lilly and Company
9.10 Gilead Science, Inc.
